Takeda Pharmaceutical Company Limited TKPHF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.73% | -209.03% | -226.21% | -43.21% | -86.54% |
| Total Depreciation and Amortization | -13.79% | -9.89% | -4.48% | -1.32% | -2.40% |
| Total Amortization of Deferred Charges | 2.23% | 2.23% | 2.23% | 20.80% | 20.80% |
| Total Other Non-Cash Items | -67.00% | 61.56% | 9.59% | 146.97% | 286.41% |
| Change in Net Operating Assets | -46.14% | 424.57% | 422.97% | -3,506.34% | 130.09% |
| Cash from Operations | -30.13% | -14.86% | -0.06% | 7.59% | 37.23% |
| Capital Expenditure | 2.89% | 8.21% | 11.23% | 7.95% | 7.64% |
| Sale of Property, Plant, and Equipment | -78.41% | -83.61% | 8,564.74% | 13,863.39% | 2,042.95% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -41.62% | -71.22% | 69.21% | 52.36% | 52.53% |
| Other Investing Activities | -177.45% | -135.47% | -25.09% | 16.23% | 57.54% |
| Cash from Investing | -76.27% | -68.77% | -0.81% | 18.87% | 40.73% |
| Total Debt Issued | -89.89% | -44.70% | -44.29% | -45.81% | -48.45% |
| Total Debt Repaid | 71.02% | 71.96% | 57.18% | 36.30% | -68.18% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 99.01% | 99.01% | 0.50% | -5,297.50% | -5,297.50% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 3.32% | 2.91% | -6.26% | -6.79% | -7.05% |
| Other Financing Activities | -8.69% | -5.30% | -62.40% | -64.40% | -87.93% |
| Cash from Financing | 38.48% | 65.27% | 33.66% | -40.95% | -3,442.56% |
| Foreign Exchange rate Adjustments | -37.17% | 233.81% | 368.66% | 208.29% | 232.77% |
| Miscellaneous Cash Flow Adjustments | -196.97% | -101.52% | -196.97% | -- | -- |
| Net Change in Cash | -50.66% | 128.53% | 380.59% | -16.62% | -131.24% |